Oppenheimer Reiterates Outperform on Immunocore Hldgs, Raises Price Target to $89
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Jeff Jones has reiterated an Outperform rating on Immunocore Holdings (NASDAQ:IMCR) and raised the price target from $87 to $89.
August 09, 2024 | 3:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Jeff Jones has reiterated an Outperform rating on Immunocore Holdings and raised the price target from $87 to $89.
The reiteration of an Outperform rating and a slight increase in the price target from $87 to $89 by a reputable analyst is likely to positively impact the stock price of Immunocore Holdings in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100